Leveraging artificial intelligence and deep learning, CureMetrix develops medical image analysis tools that empower radiologists to detect disease earlier and more accurately. Our focus is women’s health — improving mammography interpretation to support better clinical outcomes, reduce unnecessary follow-ups, and lower healthcare costs.

Founded in 2014, CureMetrix has partnered with practicing radiologists and institutions worldwide to collect and validate over 5 million images. Our product suite includes cmAssist®, cmTriage®, cmDensity™, and cmAngio®, designed to integrate into existing workflows and deliver objective, data-driven insights that help clinicians make more informed decisions.

We combine research, clinical partnerships, and regulatory best practices to translate algorithms into practical tools. CureMetrix is committed to equitable hiring and invites candidates who want to apply advanced AI to real-world healthcare problems. For open roles and more on our research initiatives, visit our careers and research pages.